Longitudinal Relationships Between Use of Highly Active Antiretroviral Therapy and Satisfaction With Care Among Women Living With HIV/AIDS

Burke-Miller, Jane K.; Cook, Judith A.; Cohen, Mardge H.; Hessol, Nancy A.; Wilson, Tracey E.; Richardson, Jean L.; Williams, Pete; Gange, Stephen J.
June 2006
American Journal of Public Health;Jun2006, Vol. 96 Issue 6, p1044
Academic Journal
Objectives. We used longitudinal data to examine the roles of 4 dimensions of patient satisfaction as both predictors and outcomes of use of highly active antiretroviral therapy (HAART) among women in the United States with HIV/AIDS. Methods. Generalized estimating equations were used to analyze time-lagged satisfaction--HAART relationships over 8 years in the Women's Interagency HIV Study. Results. Multivariate models showed that, over time, HAART use was associated with higher patient satisfaction with care in general, with providers, and with access/convenience of care; however, patient satisfaction was not associated with subsequent HAART use. Symptoms of depression and poor health-related quality of life were associated with less satisfaction with care on all 4 dimensions assessed, whereas African American race/ethnicity, illegal drug use, and fewer primary care visits were associated with less HAART use. Conclusions. Our findings suggest that dissatisfaction with care is not a reason for underuse of HAART among women with HIV and that providers should not be discouraged from recommending HAART to dissatisfied patients. Rather, increasing women's access to primary care could result in both increased HAART use and greater patient satisfaction. (Am J Public Health. 2006;96:1044-1051. doi:10.2105/AJPH.2005.061929)


Related Articles

  • Physical and emotional health outcomes after 12 months of public-sector antiretroviral treatment in the Free State Province of South Africa: a longitudinal study using structural equation modelling. Wouters, Edwin; Heunis, Christo; van Rensburg, Dingie; Meulemans, Herman // BMC Public Health;2009, Vol. 9 Issue 1, p1 

    Background: African and Asian cohort studies have demonstrated the clinical efficacy of antiretroviral treatment (ART) in resource-limited settings. However, reports of the long-term changes in the physical and emotional quality of life (QoL) of patients on ART in these settings are still...

  • Transplacental Transfer of Antiretroviral Drugs and Newborn Birth Weight in HIV-Infected Pregnant Women. Ivanovic, Jelena; Nicastri, Emanuele; Anceschi, Maurizio M.; Ascenzi, Paolo; Signore, Fabrizio; Pisani, Giuseppe; Vallone, Cristina; Mattia, Elisabetta; Notari, Stefania; Tempestilli, Massimo; Pucillo, Leopoldo P.; Narciso, Pasquale // Current HIV Research;Nov2009, Vol. 7 Issue 6, p620 

    Although it is well known that antiretroviral drugs (ARVs) across the placenta in different extents, few data are available concerning the impact of the transplacental passage of ARVs on newborn outcome. The aim of this study is to evaluate the transplacental diffusion of ARVs and the clinical...

  • Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Mayaud, P.; Nagot, N.; Konaté, I.; Ouedraogo, A.; Weiss, H. A.; Foulongne, V.; Defer, M.-C.; Sawadogo, A.; Segondy, M.; Van de Perre, P. // Sexually Transmitted Infections;Oct2008, Vol. 84 Issue 5, p332 

    Objectives: To document the natural history of herpes simplex virus type 2 (HSV-2) in relation to HIV and highly active antiretroviral therapy (HAART) in Africa, a longitudinal study was conducted of women in the placebo arms of two randomised controlled trials of HSV-suppressive therapy in...

  • Women Facing HIV. Key Question on Women with HIV Infection: Italian Consensus Workshop. Carosi, G.; Nasta, P.; Fiore, S.; Matteelli, A.; Cauda, R.; Ferrazzi, E.; Tamburrini, E.; Savasi, V.; Bini, T.; Ravizza, M.; Bucceri, A.; Vichi, F.; Murri, R.; Mazzotta, F.; Monforte, A. d'Arminio // Infection;Apr2009, Vol. 37 Issue 2, p168 

    A panel of leading Italian specialists in infectious diseases, obstetrics and gynaecology met in a national consensus workshop on women facing HIV to review critical aspects and discuss recommendations for selected key questions on four issues: (1) women and highly active antiretroviral therapy...

  • Antiretrovirals.  // Reactions Weekly;2/7/2009, Issue 1238, p7 

    The article describes the case of a 37-year-old HIV-positive woman who developed immune reconstruction syndrome (IRS) and a JC virus (JCV)-associated inflammatory pseudotumour during treatment with antiretrovirals. The patient received highly active antiretroviral therapy (HAART) which made her...

  • Symptom Exacerbation and Adherence to Antiretroviral Therapy During the Menstrual Cycle: A Pilot Study. Patel, Pinaki N.; Rimes, Richard M. // Infectious Diseases in Obstetrics & Gynecology;2006, Vol. 2006, p1 

    Our objective is to investigate the relationship between drug and menstrual cycle symptoms in HIV+ women receiving antiretroviral therapy (HAART). Interviews were done for 12 weeks with 54 HIV+ women receiving HAART. Patients were asked if they experienced any of 28 symptoms associated with...

  • Antiretroviral Drug Use during Pregnancy and Risk of Premature Delivery: Is There a Connection? Kourtis, Athena P. // Journal of Infectious Diseases;4/1/2010, Vol. 201 Issue 7, p978 

    In this article the author discusses the study by Kunjal Patel and colleagues which determines the relation of using antiretroviral therapy during pregnancy and the risk of premature delivery. He states that the study is a significant step in elucidating the subject matter at issue, but stresses...

  • Postpartum Discontinuation of Antiretroviral Therapy and Risk of Maternal AIDS-Defining Events, Non-AIDS–Defining Events, and Mortality Among a Cohort of HIV-1–Infected Women in the United States. Melekhin, Vlada V.; Shepherd, Bryan E.; Jenkins, Cathy A.; Stinnette, Samuel E.; Rebeiro, Peter F.; Bebawy, Sally S.; Rasbach, Daniel A.; Hulgan, Todd; Sterling, Timothy R. // AIDS Patient Care & STDs;May2010, Vol. 24 Issue 5, p279 

    This retrospective cohort study of HIV-infected women receiving highly active antiretroviral therapy (HAART) while pregnant assessed the effect of postpartum HAART discontinuation on maternal AIDS-defining events (ADEs), non-AIDS–defining events (non-ADEs), and death 1997–2008 in...

  • Assessing the effect of HAART on change in quality of life among HIV-infected women. Chenglong Liu; Weber, Kathleen; Robinson, Esther; Zheng Hui; Jacobson, Lisa P; Gange, Stephen J // AIDS Research & Therapy;2006, Vol. 3, p6 

    Background: The impact of highly active antiretroviral therapy (HAART) on health-related quality of life (QOL) of HIV-1 infected individuals in large prospective cohorts has not been well studied. Objective: To assess the effect of HAART on QOL by comparing HIV-infected women using HAART with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics